Caring for the caregiver: a systematic review characterising the experience of caregivers of older adults with advanced cancers

by Ishwaria M Subbiah, Jacob J Adashek
Published 2020-10-01

Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening

by Jacob J. Adashek, Filip Janku, Razelle Kurzrock
Published 2021-07-01

Clinical Development of PARP Inhibitors in Treating Metastatic Castration-Resistant Prostate Cancer

by Jacob J. Adashek, Rohit K. Jain, Jingsong Zhang
Published 2019-08-01

The paradox of cancer genes in non-malignant conditions: implications for precision medicine

by Jacob J. Adashek, Shumei Kato, Scott M. Lippman, Razelle Kurzrock
Published 2020-02-01

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer

by Jacob J. Adashek, Pedro Nazareth Aguiar Junior, Natalie Galanina, Razelle Kurzrock
Published 2019-05-01

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma

by Jacob J. Adashek, Meghan Salgia, Nazli Dizman, Jonathan Kessler, Sumanta K. Pal
Published 2018-05-01

Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer

by Jacob J. Adashek, Yadis Arroyo-Martinez, Arjun K. Menta, Razelle Kurzrock, Shumei Kato
Published 2020-08-01

Cancer Genetics and Therapeutic Opportunities in Urologic Practice

by Jacob J. Adashek, Alex Leonard, Jason Roszik, Arjun K. Menta, Giannicola Genovese, Vivek Subbiah, Pavlos Msaouel
Published 2020-03-01

Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor–based regimens

by Shumei Kato, Ryosuke Okamura, Jacob J. Adashek, Noor Khalid, Suzanna Lee, Van Nguyen, Jason K. Sicklick, Razelle Kurzrock
Published 2021-01-01

Dissecting Outcomes: Should Cytoreductive Nephrectomy Be Performed for Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation?

by Jacob J. Adashek, Yumeng Zhang, William Paul Skelton, Alyssa Bilotta, Jad Chahoud, Logan Zemp, Jiannong Li, Jasreman Dhillon, Brandon Manley, Philippe E. Spiess
Published 2021-02-01

A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors

by Mariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, Ana Cláudia Barbin Spinosa, Barbara de Souza Gutierres, Gilberto Lopes, Auro del Giglio, Pedro Nazareth Aguiar Jr
Published 2018-11-01

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

by Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Scott M. Lippman, Jason K. Sicklick, Razelle Kurzrock
Published 2020-10-01